Literature DB >> 27313773

miR-494 inhibits ovarian cancer cell proliferation and promotes apoptosis by targeting FGFR2.

Xiaojuan Zhao1, Yun Zhou1, Y U Chen1, Feng Yu1.   

Abstract

MicroRNAs (miRs) have been reported to be key regulators in numerous types of cancer. The aim of the present study was to investigate the role of miR-494 in ovarian cancer. Expression of miR-494 was analyzed in ovarian cancer tissues and cell lines by reverse transcription-quantitative polymerase chain reaction (RT-qPCR). miR-494 mimic or negative control was transiently transfected into A2780 and SKOV3 cell lines. A cell counting kit-8 assay was performed to assess the effects of miR-494 on cell proliferation, and flow cytometry was used to evaluate the apoptotic rate. The target gene of miR-494 was detected by luciferase assay. Expression of fibroblast growth factor receptor 2 (FGFR2) was identified using RT-qPCR and western blotting. In the present study, decreased expression of miR-494 was observed in ovarian cancer samples and cell lines. Overexpression of miR-494 inhibited ovarian cancer cell proliferation by inducing apoptosis. Additional investigation indicated that FGFR2 was a direct target of miR-494. Taken together, the results of the present study suggested that miR-494 suppressed ovarian cancer cell proliferation by inducing apoptosis via targeting FGFR2.

Entities:  

Keywords:  apoptosis; fibroblast growth receptor 2; microRNA-494; ovarian cancer; proliferation

Year:  2016        PMID: 27313773      PMCID: PMC4888167          DOI: 10.3892/ol.2016.4527

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  37 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

Review 2.  [MicroRNAs: novel biomarkers for human cancer].

Authors:  Claudine L Bartels; Gregory J Tsongalis
Journal:  Ann Biol Clin (Paris)       Date:  2010 May-Jun       Impact factor: 0.459

3.  Inhibition of FGFR2 and FGFR1 increases cisplatin sensitivity in ovarian cancer.

Authors:  Claire Cole; Sin Lau; Alison Backen; Andrew Clamp; Graham Rushton; Caroline Dive; Cassandra Hodgkinson; Rhona McVey; Henry Kitchener; Gordon C Jayson
Journal:  Cancer Biol Ther       Date:  2010-09-04       Impact factor: 4.742

4.  MicroRNA-494 downregulates KIT and inhibits gastrointestinal stromal tumor cell proliferation.

Authors:  Won Kyu Kim; Misun Park; Young-Kook Kim; You Kwon Tae; Han-Kwang Yang; Jae Myun Lee; Hoguen Kim
Journal:  Clin Cancer Res       Date:  2011-10-31       Impact factor: 12.531

5.  MicroRNA-494 suppresses cell proliferation and induces senescence in A549 lung cancer cells.

Authors:  H Ohdaira; M Sekiguchi; K Miyata; K Yoshida
Journal:  Cell Prolif       Date:  2011-12-13       Impact factor: 6.831

6.  Fibroblast growth factor receptor 2: expression, roles, and potential as a novel molecular target for colorectal cancer.

Authors:  Yoko Matsuda; Junji Ueda; Toshiyuki Ishiwata
Journal:  Patholog Res Int       Date:  2012-06-04

7.  miR-494-3p Regulates Cellular Proliferation, Invasion, Migration, and Apoptosis by PTEN/AKT Signaling in Human Glioblastoma Cells.

Authors:  Xue-Tao Li; Hang-Zhou Wang; Zhi-Wu Wu; Tian-Quan Yang; Zhao-Hui Zhao; Gui-Lin Chen; Xue-Shun Xie; Bin Li; Yong-Xin Wei; Yu-Lun Huang; You-Xin Zhou; Zi-Wei Du
Journal:  Cell Mol Neurobiol       Date:  2015-02-08       Impact factor: 5.046

Review 8.  Regulation of Metastasis by microRNAs in Ovarian Cancer.

Authors:  Yongchao Wang; Sangmi Kim; Il-Man Kim
Journal:  Front Oncol       Date:  2014-06-10       Impact factor: 6.244

9.  Differential microRNA expression signatures and cell type-specific association with Taxol resistance in ovarian cancer cells.

Authors:  Yong-Wan Kim; Eun Young Kim; Doin Jeon; Juinn-Lin Liu; Helena Suhyun Kim; Jin Woo Choi; Woong Shick Ahn
Journal:  Drug Des Devel Ther       Date:  2014-02-24       Impact factor: 4.162

10.  MiR-124 inhibits the migration and invasion of ovarian cancer cells by targeting SphK1.

Authors:  Hanwen Zhang; Qiuyu Wang; Qian Zhao; Wen Di
Journal:  J Ovarian Res       Date:  2013-11-26       Impact factor: 4.234

View more
  19 in total

1.  miR-381-3p suppresses the proliferation of oral squamous cell carcinoma cells by directly targeting FGFR2.

Authors:  Xiao Yang; Huibing Ruan; Xi Hu; Anyi Cao; Li Song
Journal:  Am J Cancer Res       Date:  2017-04-01       Impact factor: 6.166

Review 2.  MicroRNAs in gynecological cancers: Small molecules with big implications.

Authors:  Sanjeev K Srivastava; Aamir Ahmad; Haseeb Zubair; Orlandric Miree; Seema Singh; Rodney P Rocconi; Jennifer Scalici; Ajay P Singh
Journal:  Cancer Lett       Date:  2017-05-24       Impact factor: 8.679

Review 3.  Oncogenic and Tumor-Suppressive Roles of MicroRNAs with Special Reference to Apoptosis: Molecular Mechanisms and Therapeutic Potential.

Authors:  Dharambir Kashyap; Hardeep Singh Tuli; Vivek Kumar Garg; Neelam Goel; Anupam Bishayee
Journal:  Mol Diagn Ther       Date:  2018-04       Impact factor: 4.074

4.  Infantile hemangioma: factors causing recurrence after propranolol treatment.

Authors:  Lei Chang; Dongze Lv; Zhang Yu; Gang Ma; Hanru Ying; Yajing Qiu; Yifei Gu; Yunbo Jin; Hui Chen; Xiaoxi Lin
Journal:  Pediatr Res       Date:  2017-10-11       Impact factor: 3.756

5.  Survivin is a novel transcription regulator of KIT and is downregulated by miRNA-494 in gastrointestinal stromal tumors.

Authors:  SeongJu Yun; Won Kyu Kim; Yujin Kwon; Mi Jang; Sebastian Bauer; Hoguen Kim
Journal:  Int J Cancer       Date:  2018-01-22       Impact factor: 7.396

6.  Overexpression of miR-664 is associated with poor overall survival and accelerates cell proliferation, migration and invasion in hepatocellular carcinoma.

Authors:  Xianming Wang; Zhengtong Zhou; Tao Zhang; Minghai Wang; Rongwei Xu; Shiyong Qin; Shuguang Zhang
Journal:  Onco Targets Ther       Date:  2019-03-28       Impact factor: 4.147

7.  miR‑494 inhibits cell proliferation and metastasis via targeting of CDK6 in osteosarcoma.

Authors:  Wei Yuan; Du Wang; Yang Liu; Dongdong Tian; Yang Wang; Ranxi Zhang; Liangjun Yin; Zhongliang Deng
Journal:  Mol Med Rep       Date:  2017-10-04       Impact factor: 2.952

8.  Over-expressed microRNA-181a reduces glomerular sclerosis and renal tubular epithelial injury in rats with chronic kidney disease via down-regulation of the TLR/NF-κB pathway by binding to CRY1.

Authors:  Lei Liu; Xin-Lu Pang; Wen-Jun Shang; Hong-Chang Xie; Jun-Xiang Wang; Gui-Wen Feng
Journal:  Mol Med       Date:  2018-09-18       Impact factor: 6.354

9.  MicroRNA‑665 suppresses the growth and migration of ovarian cancer cells by targeting HOXA10.

Authors:  Jinhui Liu; Yi Jiang; Yicong Wan; Shulin Zhou; Sunita Thapa; Wenjun Cheng
Journal:  Mol Med Rep       Date:  2018-07-05       Impact factor: 2.952

10.  MicroRNA-30e inhibits adhesion, migration, invasion and cell cycle progression of prostate cancer cells via inhibition of the activation of the MAPK signaling pathway by downregulating CHRM3.

Authors:  Xin-Min Zheng; Peng Zhang; Man-Hua Liu; Ping Chen; Wei-Bing Zhang
Journal:  Int J Oncol       Date:  2018-11-26       Impact factor: 5.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.